Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). (Q53146225)
Jump to navigation
Jump to search
scientific article published on 15 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). |
scientific article published on 15 May 2008 |
Statements
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). (English)
1 reference
Dennis A Revicki
1 reference
Michelle P Luo
1 reference
Paul Wordsworth
1 reference
Robert L Wong
1 reference
Naijun Chen
1 reference
John C Davis
1 reference
ATLAS Study Group
1 reference
15 May 2008
1 reference
35
1 reference
7
1 reference
1346-1353
1 reference
Identifiers
1 reference